Annual SG&A:
$105.86M+$92.38M(+685.26%)Summary
- As of today, SLNO annual SG&A is $105.86 million, with the most recent change of +$92.38 million (+685.26%) on December 31, 2024.
- During the last 3 years, SLNO annual SG&A has risen by +$95.06 million (+879.65%).
- SLNO annual SG&A is now at all-time high.
Performance
SLNO SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$33.75M+$5.51M(+19.53%)Summary
- As of today, SLNO quarterly SG&A is $33.75 million, with the most recent change of +$5.51 million (+19.53%) on September 30, 2025.
- Over the past year, SLNO quarterly SG&A has dropped by -$15.44 million (-31.39%).
- SLNO quarterly SG&A is now -31.39% below its all-time high of $49.20 million, reached on September 30, 2024.
Performance
SLNO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.92B-$78.45M(-4.25%)Summary
- As of today, SLNO TTM SG&A is -$1.92 billion, with the most recent change of -$78.45 million (-4.25%) on September 30, 2025.
- Over the past year, SLNO TTM SG&A has dropped by -$2.00 billion (-2746.24%).
- SLNO TTM SG&A is now -3269.08% below its all-time high of -$57.10 million.
Performance
SLNO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
SLNO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +685.3% | -31.4% | -2746.2% |
| 3Y3 Years | +879.6% | +1347.4% | -10000.0% |
| 5Y5 Years | +1427.6% | +1396.1% | -10000.0% |
SLNO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +975.4% | -31.4% | +1347.4% | -116.1% | at low |
| 5Y | 5-Year | at high | +1427.6% | -31.4% | +1399.5% | -186.2% | at low |
| All-Time | All-Time | at high | +9291.5% | -31.4% | >+9999.0% | -3269.1% | at low |
SLNO Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $33.75M(+19.5%) | $128.55M(-10.7%) |
| Jun 2025 | - | $28.24M(-3.5%) | $144.00M(+13.7%) |
| Mar 2025 | - | $29.26M(-21.6%) | $126.65M(+19.6%) |
| Dec 2024 | $105.86M(+685.3%) | $37.30M(-24.2%) | $105.86M(+45.6%) |
| Sep 2024 | - | $49.20M(+351.8%) | $72.70M(+171.1%) |
| Jun 2024 | - | $10.89M(+28.5%) | $26.82M(+40.4%) |
| Mar 2024 | - | $8.47M(+104.6%) | $19.10M(+41.7%) |
| Dec 2023 | $13.48M(+36.9%) | $4.14M(+24.8%) | $13.48M(+14.8%) |
| Sep 2023 | - | $3.32M(+4.7%) | $11.74M(+9.2%) |
| Jun 2023 | - | $3.17M(+11.0%) | $10.76M(+7.0%) |
| Mar 2023 | - | $2.85M(+18.8%) | $10.05M(+2.1%) |
| Dec 2022 | $9.84M(-8.9%) | $2.40M(+3.0%) | $9.84M(-1.9%) |
| Sep 2022 | - | $2.33M(-5.5%) | $10.04M(-4.2%) |
| Jun 2022 | - | $2.47M(-6.7%) | $10.47M(+0.0%) |
| Mar 2022 | - | $2.64M(+1.8%) | $10.47M(-3.1%) |
| Dec 2021 | $10.81M(+23.4%) | $2.60M(-6.2%) | $10.81M(+3.3%) |
| Sep 2021 | - | $2.77M(+12.3%) | $10.46M(+5.1%) |
| Jun 2021 | - | $2.46M(-17.3%) | $9.95M(+2.2%) |
| Mar 2021 | - | $2.98M(+32.3%) | $9.73M(+11.1%) |
| Dec 2020 | $8.76M(+26.4%) | $2.25M(-0.2%) | $8.76M(+7.9%) |
| Sep 2020 | - | $2.26M(+0.4%) | $8.12M(+8.6%) |
| Jun 2020 | - | $2.25M(+12.2%) | $7.47M(+8.0%) |
| Mar 2020 | - | $2.00M(+24.6%) | $6.92M(-0.1%) |
| Dec 2019 | $6.93M | $1.61M(-0.4%) | $6.93M(+3.6%) |
| Sep 2019 | - | $1.61M(-4.7%) | $6.69M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $1.70M(-15.8%) | $6.63M(-1.1%) |
| Mar 2019 | - | $2.01M(+47.4%) | $6.70M(+2.2%) |
| Dec 2018 | $6.56M(-0.8%) | $1.36M(-12.4%) | $6.56M(-35.2%) |
| Sep 2018 | - | $1.56M(-11.8%) | $10.12M(-1.2%) |
| Jun 2018 | - | $1.77M(-5.4%) | $10.24M(-4.0%) |
| Mar 2018 | - | $1.87M(-62.1%) | $10.67M(+8.3%) |
| Dec 2017 | $6.61M(+8.8%) | $4.93M(+192.3%) | $9.85M(+40.9%) |
| Sep 2017 | - | $1.69M(-23.2%) | $6.99M(+6.5%) |
| Jun 2017 | - | $2.19M(+109.8%) | $6.57M(+10.2%) |
| Mar 2017 | - | $1.05M(-49.3%) | $5.96M(-19.4%) |
| Dec 2016 | $6.08M(-22.9%) | $2.06M(+63.8%) | $7.39M(-1.9%) |
| Sep 2016 | - | $1.26M(-20.7%) | $7.53M(-10.9%) |
| Jun 2016 | - | $1.59M(-35.9%) | $8.45M(-4.0%) |
| Mar 2016 | - | $2.48M(+12.2%) | $8.80M(+11.7%) |
| Dec 2015 | $7.88M(+170.0%) | $2.21M(+1.2%) | $7.88M(+14.0%) |
| Sep 2015 | - | $2.18M(+12.5%) | $6.91M(+29.5%) |
| Jun 2015 | - | $1.94M(+24.9%) | $5.33M(+28.4%) |
| Mar 2015 | - | $1.55M(+25.5%) | $4.15M(+42.5%) |
| Dec 2014 | $2.92M(+98.9%) | $1.24M(+104.1%) | $2.91M(+73.8%) |
| Sep 2014 | - | $606.00K(-20.1%) | $1.68M(+56.6%) |
| Jun 2014 | - | $758.00K(+142.6%) | $1.07M(+16.8%) |
| Mar 2014 | - | $312.40K(-48.3%) | $916.50K(-10.1%) |
| Dec 2013 | $1.47M(+30.1%) | - | - |
| Jun 2013 | - | $604.10K(+45.3%) | $1.02M(+145.3%) |
| Mar 2013 | - | $415.90K | $415.90K |
| Dec 2012 | $1.13M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual SG&A year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Soleno Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM SG&A year-on-year change?
What is Soleno Therapeutics, Inc. annual SG&A?
The current annual SG&A of SLNO is $105.86M
What is the all-time high annual SG&A for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual SG&A is $105.86M
What is Soleno Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, SLNO annual SG&A has changed by +$92.38M (+685.26%)
What is Soleno Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of SLNO is $33.75M
What is the all-time high quarterly SG&A for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly SG&A is $49.20M
What is Soleno Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, SLNO quarterly SG&A has changed by -$15.44M (-31.39%)
What is Soleno Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of SLNO is -$1.92B
What is the all-time high TTM SG&A for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM SG&A is -$57.10M
What is Soleno Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, SLNO TTM SG&A has changed by -$2.00B (-2746.24%)